Evidence map›Paper›PMID 39971297›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Brachial Plexitis during Maintenance Atezolizumab after Palliative Radiotherapy for Cervical Spine Metastasis in Lung Cancer.

Riko Kamada, Makoto Hibino, Saki Nakachi, Hikari Higa, Shigehiro Watanabe, Kazunari Maeda, Tetsuri Kondo

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Riko KamadaDepartment of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Japan.
Makoto HibinoDepartment of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Japan.
Saki NakachiDepartment of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Japan.
Hikari HigaDepartment of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Japan.
Shigehiro WatanabeDepartment of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Japan.
Kazunari MaedaDepartment of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Japan.
Tetsuri KondoDepartment of Respiratory Medicine, Shonan Fujisawa Tokushukai Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the case of a patient with lung cancer who developed brachial plexitis following treatment with immunochemotherapy, which included atezolizumab and palliative radiotherapy for a metastatic cervical spine tumor. This case highlights the importance of considering immune-related adverse events (irAEs) when initiating immune checkpoint inhibitor therapy, in addition to other recognized causes such as radiation, tumor compression and invasion, and paraneoplastic syndromes. While brachial plexitis has been reported as an irAE associated with programmed cell death 1 (PD-1) antibodies, this is the first report associated with the administration of programmed cell death ligand 1 (PD-L1) antibodies.

Indexed as

Antibodies, Monoclonal, HumanizedBrachial Plexus NeuropathiesCervical VertebraeLung NeoplasmsSpinal NeoplasmsHumansImmune Checkpoint InhibitorsPalliative CareAntibodies, Monoclonal, HumanizedatezolizumabImmune Checkpoint Inhibitorsbrachial plexitisimmune-related adverse eventsPD-L1 antibodies

Identifiers

PMID39971297
PMCPMC12425580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.